Share your contact details to receive free updated sample copy/pages of the recently published edition of Whole Exome Sequencing Market Report 2023.
Key Insights from Whole Exome Sequencing Market Report
As per Cognitive Market Research's latest published report, the Global Whole Exome Sequencing market size was $1.40 Billion in 2022 and it is forecasted to reach $4.71 Billion by 2030. Whole Exome Sequencing Industry's Compound Annual Growth Rate will be 18.74% from 2023 to 2030.
| Global Whole Exome Sequencing Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 18.74% |
Whole Exome Sequencing Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Whole Exome Sequencing Market Report Description
What is Whole Exome Sequencing?
Whole-exome sequencing is a common next-generation sequencing (NGS) technique that entails sequencing the genome's protein-coding regions. This technique offers a less expensive option to whole-genome sequencing because the human exome, which makes up less than 2% of the genome, contains 85% of known disease-related variations. Exome sequencing using exome enrichment can proficiently find coding changes in a wide range of applications, including, genetic disease, population genetics and cancer research.
Factors Impacting on Whole Exome Sequencing Market
The primary drivers propelling the expansion of the global exome sequencing market are the rising applications in clinical diagnostics and the rising need for uncommon illness diagnosis. The acceptance of next-generation sequencing methods for the diagnosis, prognosis, therapy, and follow-up of numerous chronic diseases, including cancer, is expanding, which is driving the industry as a whole. The acceptance of next-generation sequencing methods for the diagnosis, prognosis, therapy, and follow-up of numerous chronic diseases, including cancer, is expanding, which is driving the industry as a whole.
-
What are the opportunities and challenges for the Whole Exome Sequencing Market?
Over the anticipated time frame, the market may experience lucrative growth due to rising R&D expenditures in the fields of genomics and next-generation sequencing, as well as rising demand for personalized pharmaceuticals. However, the market's expansion may be constrained by a scarcity of qualified professionals and a significant reliance on government funding.
| Base Year | 2022 |
| Historical Data Time Period | 2018-2022 |
| Forecast Period | 2023-2030 |
| Report Edition | 7th Edition (2023) |
| Last Update | Last Updated In April 2023 |
| Next Report Edition | June 2023 (Pre-Booking Available) |
| Market Forecast/Projection Time Period | 2023-2030 |
| Report Format | PDF | PPT | Excel | Word | Bi |
| Report ID | CMR225538 |
Whole Exome Sequencing Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Whole Exome Sequencing Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Whole Exome Sequencing Market Segmentation
- 1.5.1 Whole Exome Sequencing Market Regional Fragmentation
- 1.5.1 Whole Exome Sequencing Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Whole Exome Sequencing Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Whole Exome Sequencing Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Whole Exome Sequencing industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Whole Exome Sequencing Market Size 2018 – 2030, (USD Million)
- 3.2 Global Whole Exome Sequencing Value, Absolute & Opportunity Analysis
- 3.3 Global Whole Exome Sequencing Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Whole Exome Sequencing Market Statistics 2022: Snapshot
- 4.1 Whole Exome Sequencing Introduction
- 4.2 Global Whole Exome Sequencing Market Statistics by Regions (2018-2030)
- 4.2.1 North America Whole Exome Sequencing Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Whole Exome Sequencing Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Whole Exome Sequencing Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Whole Exome Sequencing Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Whole Exome Sequencing Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Whole Exome Sequencing Market Size (2018-2030)
- 4.3.1 Global Whole Exome Sequencing Revenue Status and Outlook (2018-2030)
- 4.4 Global Whole Exome Sequencing Market Price Analysis by Regions (2018-2030)
- 5.1 Global Whole Exome Sequencing Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Whole Exome Sequencing Industry Mergers and Acquisition Analysis
- 5.3 Global Whole Exome Sequencing New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Whole Exome Sequencing Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Whole Exome Sequencing Industrial Dynamics
- 7.1.1 Global Whole Exome Sequencing Market Drivers
- 7.1.2 Global Whole Exome Sequencing Market Restrains
- 7.1.3 Global Whole Exome Sequencing Market Opportunities
- 7.1.4 Global Whole Exome Sequencing Market Trends
- 7.1.5 Global Whole Exome Sequencing Technology (Road Map)
- 7.2 Whole Exome Sequencing Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Whole Exome Sequencing Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Whole Exome Sequencing Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 of Whole Exome Sequencing Market Product Life Cycle
- 7.6 COVID-19 Impact on Whole Exome Sequencing Industry
- 7.4.1 Overall Impact of COVID-19 on Whole Exome Sequencing Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.7 Consumer Preference Analysis for Whole Exome Sequencing Market
- 7.8 Patent Analysis of Whole Exome Sequencing
- 7.9 Whole Exome Sequencing Industrial Chain Analysis
- 7.10 Manufacturing Cost Analysis
- 7.11 Supply Side Analysis
- 8.1 Illumina
- 8.1.1 Illumina Company Basic Information, and Sales Area
- 8.1.2 Illumina Business Segment/ Overview
- 8.1.3 Illumina Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 Illumina Sales Revenue (2018-2022)
- 8.1.3.3 Illumina Market Share (2018-2022)
- 8.1.4 Illumina Recent Developments
- 8.1.5 Illumina Business Strategy
- 8.1.6 Illumina Management Change
- 8.1.7 Illumina SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 Illumina COVID-19 Impact Analysis
- 8.2 Thermo Fisher
- 8.2.1 Thermo Fisher Company Basic Information, and Sales Area
- 8.2.2 Thermo Fisher Business Segment/ Overview
- 8.2.3 Thermo Fisher Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 Thermo Fisher Sales Revenue (2018-2022)
- 8.2.3.3 Thermo Fisher Market Share (2018-2022)
- 8.2.4 Thermo Fisher Recent Developments
- 8.2.5 Thermo Fisher Business Strategy
- 8.2.6 Thermo Fisher Management Change
- 8.2.7 Thermo Fisher SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 Thermo Fisher COVID-19 Impact Analysis
- 8.3 Roche
- 8.3.1 Roche Company Basic Information, and Sales Area
- 8.3.2 Roche Business Segment/ Overview
- 8.3.3 Roche Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Roche Sales Revenue (2018-2022)
- 8.3.3.3 Roche Market Share (2018-2022)
- 8.3.4 Roche Recent Developments
- 8.3.5 Roche Business Strategy
- 8.3.6 Roche Management Change
- 8.3.7 Roche SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Roche COVID-19 Impact Analysis
- 8.4 Angilent
- 8.4.1 Angilent Company Basic Information, and Sales Area
- 8.4.2 Angilent Business Segment/ Overview
- 8.4.3 Angilent Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Angilent Sales Revenue (2018-2022)
- 8.4.3.3 Angilent Market Share (2018-2022)
- 8.4.4 Angilent Recent Developments
- 8.4.5 Angilent Business Strategy
- 8.4.6 Angilent Management Change
- 8.4.7 Angilent SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Angilent COVID-19 Impact Analysis
- 8.5 Eurofins
- 8.5.1 Eurofins Company Basic Information, and Sales Area
- 8.5.2 Eurofins Business Segment/ Overview
- 8.5.3 Eurofins Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Eurofins Sales Revenue (2018-2022)
- 8.5.3.3 Eurofins Market Share (2018-2022)
- 8.5.4 Eurofins Recent Developments
- 8.5.5 Eurofins Business Strategy
- 8.5.6 Eurofins Management Change
- 8.5.7 Eurofins SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Eurofins COVID-19 Impact Analysis
- 8.6 Sengenics
- 8.6.1 Sengenics Company Basic Information, and Sales Area
- 8.6.2 Sengenics Business Segment/ Overview
- 8.6.3 Sengenics Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 Sengenics Sales Revenue (2018-2022)
- 8.6.3.3 Sengenics Market Share (2018-2022)
- 8.6.4 Sengenics Recent Developments
- 8.6.5 Sengenics Business Strategy
- 8.6.6 Sengenics Management Change
- 8.6.7 Sengenics SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 Sengenics COVID-19 Impact Analysis
- 8.7 Ambry
- 8.7.1 Ambry Company Basic Information, and Sales Area
- 8.7.2 Ambry Business Segment/ Overview
- 8.7.3 Ambry Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 Ambry Sales Revenue (2018-2022)
- 8.7.3.3 Ambry Market Share (2018-2022)
- 8.7.4 Ambry Recent Developments
- 8.7.5 Ambry Business Strategy
- 8.7.6 Ambry Management Change
- 8.7.7 Ambry SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 Ambry COVID-19 Impact Analysis
- 8.8 Macrogen
- 8.8.1 Macrogen Company Basic Information, and Sales Area
- 8.8.2 Macrogen Business Segment/ Overview
- 8.8.3 Macrogen Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 Macrogen Sales Revenue (2018-2022)
- 8.8.3.3 Macrogen Market Share (2018-2022)
- 8.8.4 Macrogen Recent Developments
- 8.8.5 Macrogen Business Strategy
- 8.8.6 Macrogen Management Change
- 8.8.7 Macrogen SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 Macrogen COVID-19 Impact Analysis
- 8.9 BGI
- 8.9.1 BGI Company Basic Information, and Sales Area
- 8.9.2 BGI Business Segment/ Overview
- 8.9.3 BGI Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 BGI Sales Revenue (2018-2022)
- 8.9.3.3 BGI Market Share (2018-2022)
- 8.9.4 BGI Recent Developments
- 8.9.5 BGI Business Strategy
- 8.9.6 BGI Management Change
- 8.9.7 BGI SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 BGI COVID-19 Impact Analysis
- 8.10 Novo Gene
- 8.10.1 Novo Gene Company Basic Information, and Sales Area
- 8.10.2 Novo Gene Business Segment/ Overview
- 8.10.3 Novo Gene Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Novo Gene Sales Revenue (2018-2022)
- 8.10.3.3 Novo Gene Market Share (2018-2022)
- 8.10.4 Novo Gene Recent Developments
- 8.10.5 Novo Gene Business Strategy
- 8.10.6 Novo Gene Management Change
- 8.10.7 Novo Gene SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Novo Gene COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Whole Exome Sequencing Revenue and Share (%) by Product Type (2018-2030)
- 9.2.1 Systems Market Size
- 9.2.1.1 Global Systems Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Whole Exome Sequencing Market for Systems, by Country (2021 Vs 2024)
- 9.2.2 Services Market Size
- 9.2.2.1 Global Services Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Whole Exome Sequencing Market for Services, by Country (2021 Vs 2024)
- 9.2.3 Kits Market Size
- 9.2.3.1 Global Kits Market Share and Revenue (USD Million) for 2018-2030
- 9.2.3.2 Whole Exome Sequencing Market for Kits, by Country (2021 Vs 2024)
- 9.2.1 Systems Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Whole Exome Sequencing Revenue and Share (%) by Application (2018-2030)
- 10.2.1 Diagnostics Market Size
- 10.2.1.1 Global Diagnostics Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Whole Exome Sequencing Market for Diagnostics, by Country (2021 Vs 2024)
- 10.2.2 Personalized Medicine Market Size
- 10.2.2.1 Global Personalized Medicine Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Whole Exome Sequencing Market for Personalized Medicine, by Country (2021 Vs 2024)
- 10.2.3 Agriculture and Animal Research Market Size
- 10.2.3.1 Global Agriculture and Animal Research Market Share and Revenue (USD Million) for 2018-2030
- 10.2.3.2 Whole Exome Sequencing Market for Agriculture and Animal Research, by Country (2021 Vs 2024)
- 10.2.4 Drug Discovery and Development Market Size
- 10.2.4.1 Global Drug Discovery and Development Market Share and Revenue (USD Million) for 2018-2030
- 10.2.4.2 Whole Exome Sequencing Market for Drug Discovery and Development, by Country (2021 Vs 2024)
- 10.2.5 Others Market Size
- 10.2.5.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 10.2.5.2 Whole Exome Sequencing Market for Others, by Country (2021 Vs 2024)
- 10.2.1 Diagnostics Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Whole Exome Sequencing Revenue and Share (%) by End-User (2018-2030)
- 11.2.1 Academic and Government Institutions Market Size
- 11.2.1.1 Global Academic and Government Institutions Market Share and Revenue (USD Million) for 2018-2030
- 11.2.1.2 Whole Exome Sequencing Market for Academic and Government Institutions, by Country (2021 Vs 2024)
- 11.2.2 Pharmaceutical Companies Market Size
- 11.2.2.1 Global Pharmaceutical Companies Market Share and Revenue (USD Million) for 2018-2030
- 11.2.2.2 Whole Exome Sequencing Market for Pharmaceutical Companies, by Country (2021 Vs 2024)
- 11.2.3 Research Center Market Size
- 11.2.3.1 Global Research Center Market Share and Revenue (USD Million) for 2018-2030
- 11.2.3.2 Whole Exome Sequencing Market for Research Center, by Country (2021 Vs 2024)
- 11.2.4 Hospitals and Clinics Market Size
- 11.2.4.1 Global Hospitals and Clinics Market Share and Revenue (USD Million) for 2018-2030
- 11.2.4.2 Whole Exome Sequencing Market for Hospitals and Clinics, by Country (2021 Vs 2024)
- 11.2.5 Others Market Size
- 11.2.5.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 11.2.5.2 Whole Exome Sequencing Market for Others, by Country (2021 Vs 2024)
- 11.2.1 Academic and Government Institutions Market Size
- 12.1 Detailed Qualitative Analysis
- 12.2 Global Whole Exome Sequencing Market Revenue by Region (2018-2030)
- 12.2 Global Whole Exome Sequencing Market Share (%) by Region (2018-2030)
- 13.1 North America
- 13.1.1 North America Whole Exome Sequencing Market Trends and Analysis
- 13.1.2 North America Whole Exome Sequencing Market by Country, 2018-2030
- 13.1.3 North America Whole Exome Sequencing Market Attractiveness Analysis by Country
- 13.2 North America Whole Exome Sequencing Market Size (2018-2030)
- 13.2.1 North America Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 13.2.1.1 Systems
- 13.2.1.1.1 North America Systems Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Services
- 13.2.1.2.1 North America Services Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Kits
- 13.2.1.3.1 North America Kits Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Systems
- 13.2.2 North America Whole Exome Sequencing Market (USD Million) by Application (2018-2030)
- 13.2.2.1 Diagnostics
- 13.2.2.1.1 North America Diagnostics Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Personalized Medicine
- 13.2.2.2.1 North America Personalized Medicine Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.3 Agriculture and Animal Research
- 13.2.2.3.1 North America Agriculture and Animal Research Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.4 Drug Discovery and Development
- 13.2.2.4.1 North America Drug Discovery and Development Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.5 Others
- 13.2.2.5.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Diagnostics
- 13.2.3 North America Whole Exome Sequencing Market (USD Million) by End-User (2018-2030)
- 13.2.3.1 Academic and Government Institutions
- 13.2.3.1.1 North America Academic and Government Institutions Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Pharmaceutical Companies
- 13.2.3.2.1 North America Pharmaceutical Companies Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.3 Research Center
- 13.2.3.3.1 North America Research Center Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.4 Hospitals and Clinics
- 13.2.3.4.1 North America Hospitals and Clinics Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.5 Others
- 13.2.3.5.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.1 Academic and Government Institutions
- 13.2.1 North America Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 14.1 Europe
- 14.1.1 Europe Whole Exome Sequencing Market Trends and Analysis
- 14.1.2 Europe Whole Exome Sequencing Market by Country, 2018-2030
- 14.1.3 Europe Whole Exome Sequencing Market Attractiveness Analysis by Country
- 14.2 Europe Whole Exome Sequencing Market Size (2018-2030)
- 14.2.1 Europe Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 14.2.1.1 Systems
- 14.2.1.1.1 Europe Systems Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Services
- 14.2.1.2.1 Europe Services Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Kits
- 14.2.1.3.1 Europe Kits Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Systems
- 14.2.2 Europe Whole Exome Sequencing Market (USD Million) by Application (2018-2030)
- 14.2.2.1 Diagnostics
- 14.2.2.1.1 Europe Diagnostics Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Personalized Medicine
- 14.2.2.2.1 Europe Personalized Medicine Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Agriculture and Animal Research
- 14.2.2.3.1 Europe Agriculture and Animal Research Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.4 Drug Discovery and Development
- 14.2.2.4.1 Europe Drug Discovery and Development Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.5 Others
- 14.2.2.5.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Diagnostics
- 14.2.3 Europe Whole Exome Sequencing Market (USD Million) by End-User (2018-2030)
- 14.2.3.1 Academic and Government Institutions
- 14.2.3.1.1 Europe Academic and Government Institutions Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Pharmaceutical Companies
- 14.2.3.2.1 Europe Pharmaceutical Companies Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Research Center
- 14.2.3.3.1 Europe Research Center Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Hospitals and Clinics
- 14.2.3.4.1 Europe Hospitals and Clinics Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.5 Others
- 14.2.3.5.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 Academic and Government Institutions
- 14.2.1 Europe Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 15.1 Asia Pacific
- 15.1.1 Asia Pacific Whole Exome Sequencing Market Trends and Analysis
- 15.1.2 Asia Pacific Whole Exome Sequencing Market by Country, 2018-2030
- 15.1.3 Asia Pacific Whole Exome Sequencing Market Attractiveness Analysis by Country
- 15.2 Asia Pacific Whole Exome Sequencing Market Size (2018-2030)
- 15.2.1 Asia Pacific Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 15.2.1.1 Systems
- 15.2.1.1.1 Asia Pacific Systems Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Services
- 15.2.1.2.1 Asia Pacific Services Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Kits
- 15.2.1.3.1 Asia Pacific Kits Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Systems
- 15.2.2 Asia Pacific Whole Exome Sequencing Market (USD Million) by Application (2018-2030)
- 15.2.2.1 Diagnostics
- 15.2.2.1.1 Asia Pacific Diagnostics Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Personalized Medicine
- 15.2.2.2.1 Asia Pacific Personalized Medicine Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Agriculture and Animal Research
- 15.2.2.3.1 Asia Pacific Agriculture and Animal Research Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.4 Drug Discovery and Development
- 15.2.2.4.1 Asia Pacific Drug Discovery and Development Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.5 Others
- 15.2.2.5.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Diagnostics
- 15.2.3 Asia Pacific Whole Exome Sequencing Market (USD Million) by End-User (2018-2030)
- 15.2.3.1 Academic and Government Institutions
- 15.2.3.1.1 Asia Pacific Academic and Government Institutions Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Pharmaceutical Companies
- 15.2.3.2.1 Asia Pacific Pharmaceutical Companies Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Research Center
- 15.2.3.3.1 Asia Pacific Research Center Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Hospitals and Clinics
- 15.2.3.4.1 Asia Pacific Hospitals and Clinics Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.5 Others
- 15.2.3.5.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 Academic and Government Institutions
- 15.2.1 Asia Pacific Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 16.1 Latin America
- 16.1.1 Latin America Whole Exome Sequencing Market Trends and Analysis
- 16.1.2 Latin America Whole Exome Sequencing Market by Country, 2018-2030
- 16.1.3 Latin America Whole Exome Sequencing Market Attractiveness Analysis by Country
- 16.2 Latin America Whole Exome Sequencing Market Size (2018-2030)
- 16.2.1 Latin America Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 16.2.1.1 Systems
- 16.2.1.1.1 Latin America Systems Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Services
- 16.2.1.2.1 Latin America Services Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Kits
- 16.2.1.3.1 Latin America Kits Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Systems
- 16.2.2 Latin America Whole Exome Sequencing Market (USD Million) by Application (2018-2030)
- 16.2.2.1 Diagnostics
- 16.2.2.1.1 Latin America Diagnostics Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Personalized Medicine
- 16.2.2.2.1 Latin America Personalized Medicine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Agriculture and Animal Research
- 16.2.2.3.1 Latin America Agriculture and Animal Research Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.4 Drug Discovery and Development
- 16.2.2.4.1 Latin America Drug Discovery and Development Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.5 Others
- 16.2.2.5.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Diagnostics
- 16.2.3 Latin America Whole Exome Sequencing Market (USD Million) by End-User (2018-2030)
- 16.2.3.1 Academic and Government Institutions
- 16.2.3.1.1 Latin America Academic and Government Institutions Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Pharmaceutical Companies
- 16.2.3.2.1 Latin America Pharmaceutical Companies Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Research Center
- 16.2.3.3.1 Latin America Research Center Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Hospitals and Clinics
- 16.2.3.4.1 Latin America Hospitals and Clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.5 Others
- 16.2.3.5.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 Academic and Government Institutions
- 16.2.1 Latin America Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 17.1 Middle East and Africa
- 17.1.1 Middle East and Africa Whole Exome Sequencing Market Trends and Analysis
- 17.1.2 Middle East and Africa Whole Exome Sequencing Market by Country, 2018-2030
- 17.1.3 Middle East and Africa Whole Exome Sequencing Market Attractiveness Analysis by Country
- 17.2 Middle East and Africa Whole Exome Sequencing Market Size (2018-2030)
- 17.2.1 Middle East and Africa Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 17.2.1.1 Systems
- 17.2.1.1.1 Middle East and Africa Systems Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Services
- 17.2.1.2.1 Middle East and Africa Services Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Kits
- 17.2.1.3.1 Middle East and Africa Kits Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Systems
- 17.2.2 Middle East and Africa Whole Exome Sequencing Market (USD Million) by Application (2018-2030)
- 17.2.2.1 Diagnostics
- 17.2.2.1.1 Middle East and Africa Diagnostics Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Personalized Medicine
- 17.2.2.2.1 Middle East and Africa Personalized Medicine Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Agriculture and Animal Research
- 17.2.2.3.1 Middle East and Africa Agriculture and Animal Research Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.4 Drug Discovery and Development
- 17.2.2.4.1 Middle East and Africa Drug Discovery and Development Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.5 Others
- 17.2.2.5.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Diagnostics
- 17.2.3 Middle East and Africa Whole Exome Sequencing Market (USD Million) by End-User (2018-2030)
- 17.2.3.1 Academic and Government Institutions
- 17.2.3.1.1 Middle East and Africa Academic and Government Institutions Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Pharmaceutical Companies
- 17.2.3.2.1 Middle East and Africa Pharmaceutical Companies Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Research Center
- 17.2.3.3.1 Middle East and Africa Research Center Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Hospitals and Clinics
- 17.2.3.4.1 Middle East and Africa Hospitals and Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.5 Others
- 17.2.3.5.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 Academic and Government Institutions
- 17.2.1 Middle East and Africa Whole Exome Sequencing Market (USD Million) by Product Type (2018-2030)
- 18.1 Key Takeaways
- 18.2 Analyst Point of View
- 18.3 Assumptions
| Segmentation Level Customization | |
| Global level Data Customization | |
| Region level Data Customization | |
| Country level Data Customization | |
| Company Level | |
| Additional Data Analysis | |
| Additional Qualitative Data | |
| Additional Quantitative Data | |
| Service Level Customization | Report Format Alteration |
We have various report editions of Whole Exome Sequencing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Whole Exome Sequencing Market Analysis
Global Whole Exome Sequencing Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Whole Exome Sequencing Industry growth. Whole Exome Sequencing market has been segmented with the help of its Product Type, Application End-User, and others. Whole Exome Sequencing market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Whole Exome Sequencing industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
| Major Product Type Analysed |
|
| Major Application Analysed |
|
| Major End-User Analysed |
|
| Top Manufacturers Disclosed |
|
| Global, Regional and Country Analysis |
|
| Key Qualitative Information Covered |
|
By Product Type, the Systems segment dominated Whole Exome Sequencing Market!
The market is divided into systems, services, and kits depending on the type of product. The market is dominated by the systems segment, and during the forecast period, the kits segment is expected to develop at the fastest Rate.
- Systems
- Services
- Kits
Whole Exome Sequencing Market Share (%) by Product Type in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Whole Exome Sequencing Industry. Request a Free Sample PDF!
Application Segment Analysis of Whole Exome Sequencing Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Whole Exome Sequencing from 2018 to 2030. This will also help to analyze the demand for Whole Exome Sequencing across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Application of Whole Exome Sequencing are:
- Diagnostics
- Personalized Medicine
- Agriculture and Animal Research
- Drug Discovery and Development
- Others
Whole Exome Sequencing Market Share (%) by Application in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Whole Exome Sequencing market report 2023 Edition by contacting our team.
Whole Exome Sequencing End-User Segment Analysis
- Academic and Government Institutions
- Pharmaceutical Companies
- Research Center
- Hospitals and Clinics
- Others
Whole Exome Sequencing Market Regional Analysis
Region and country analysis section of Whole Exome Sequencing Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Whole Exome Sequencing market.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Whole Exome Sequencing Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Whole Exome Sequencing Market News:
- Illumina Unveiled Novel Sequencing Technology, Roche Collaboration, and Software Package to Speed Up Genomics Adoption (January 2020)
In order to hasten the release of distributable NGS-based in-vitro diagnostic (IVD) tests using Illumina's diagnostic (Dx) sequencing systems, Illumina and Roche, one of the top diagnostic firms in the world, have signed a 15-year, non-exclusive collaboration agreement. Also, Roche and Illumina will work together to add additional companion diagnostic (CDx) claims to Illumina's comprehensive pan-cancer assay TruSight Oncology 500 (TSO 500).
Top Companies Market Share in Whole Exome Sequencing Industry: (In no particular order of Rank)
- Illumina
- Thermo Fisher
- Roche
- Angilent
- Eurofins
- Sengenics
- Ambry
- Macrogen
- BGI
- Novo Gene
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Whole Exome Sequencing Market is witnessing significant growth in the near future.
In 2022, the Systems segment accounted for noticeable share of global Whole Exome Sequencing Market and is projected to experience significant growth in the near future.
The Diagnostics segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Illumina, Roche and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Author's Detail
Supriya R Ghadge, LinkedIn
Senior Research Analyst at Cognitive Market Research
I am working as a Senior Research Analyst, mainly involved in conducting market research in the Information and Communication, and Technology domain. Skilled in Secondary Research, Primary Research, Data Analytics Research approaches with extensive experience providing first-class results. Highly focused, have analytical skills, and synergetic with positive energizers. Meets job demands and deadlines through diligent work-ethic and dedication to quality. Works with clients to determine requirements and provide excellent service.
Key Questions Answered By Whole Exome Sequencing Market Report 2023
| Why Systems have a significant impact on Whole Exome Sequencing market? |
| What are the key factors affecting the Systems and Services of Whole Exome Sequencing Market? |
| What is the CAGR/Growth Rate of Diagnostics during the forecast period? |
| By type, which segment accounted for largest share of the global Whole Exome Sequencing Market? |
| Which region is expected to dominate the global Whole Exome Sequencing Market within the forecast period? |
Frequently Asked Questions
Whole Exome Sequencing market size and its growth rate has been provided in the report. The historical period included in the report is from 2018 to 2022, whereas, the report provides forecast data for the years 2023 to 2030. This will help you to in terms of global market share, regional market share, country level market share to understand how the market has been performing in the past and how it is going to perform in the following years. Correspondingly, historical and forecast analysis comprises sales and revenue data of the global Whole Exome Sequencing market. Market size for UK, Europe, North America, Asia Pacific, Middle East & Africa is also included in the report.
The major factors affecting the Whole Exome Sequencing market in a positive, as well as negative perspective, have been provided with detailed analysis in the report. This segment has encompassed drivers, opportunities, and challenges faced by the industry. This will help you to understand the major factors impacting Whole Exome Sequencing market trends and develop your business strategy accordingly.
Major manufacturers or list of Whole Exome Sequencing manufacturers 2023 involved in the market have been profiled in the report along with their business strategies, recent developments, SWOT analysis, business overview, and market Trend from the year 2018-2022. Whole Exome Sequencing Companies such as Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene are part of the final deliverable document along with the same we can provide data for 2nd, 3rd, start-up level companies data and strategies as well . This will help you to understand the competitive analysis of the market and how other players are performing in the market. This detailed competitive analysis will help you to strategize your business accordingly and will keep you one step ahead. A quantitative and qualitative analysis of the main players in the Whole Exome Sequencing market is introduced, from the perspective of sales, revenue and price.
Under Whole Exome Sequencing market segments analysis Product Type, Application End-User. It provides detailed insights on each type and application. Further, it provides which sub-segment is dominating the Whole Exome Sequencing market along with its reason. Additionally, the Whole Exome Sequencing market report will help you to analyze which sub-segment is fastest-growing during the forecast period.
After the analysis of the complete market, the report has provided how the COVID-19 pandemic has affected the market. All the parameters have covered the overall impact of COVID -19 on the market value, market trend & growth of the market, and how the major players in the particular market are adopting these changes. This will help you to understand the overall optimistic, pessimistic, and neutral effects of the coronavirus pandemic on the Whole Exome Sequencing market.
The Whole Exome Sequencing market has been analyzed thoroughly and has estimated the parameters which have affected the market in the historical period as well as how the market is going to perform in the following years. This will provide a complete market scenario and help you to strategize your next move accordingly to the Whole Exome Sequencing market Share.
The report gives an exhaustive investigation of the Whole Exome Sequencing market at country & regional levels, and provides an analysis of the industry trends in each of the regions, from sales, revenue, and consumption. It will help you to understand which region is dominating the market and is expected to grow significantly in the following years. The regional analysis will help you in strategizing the expansion of business.
Whole Exome Sequencing market report has provided PESTEL and Porter analysis to provide insightful information regarding the market scenario. It also provides market attractiveness analysis with an acknowledgment of various factors within the market, including growth rate and market size, as well as outside factors such as access to raw materials, competition, and industry capacity.
The sample report for the Whole Exome Sequencing Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
Related Reports
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Whole Exome Sequencing market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Whole Exome Sequencing market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more
